Such good news in oncology is unheard of a priori. Immunotherapy alone treated fourteen patients in clinical trials conducted by the Memorial Sloan Kettering Cancer Center in New York. The results are published New England Journal of Medicine (NEJM) ներկայաց A few days ago at the US Congress of Oncology in Chicago, the more impressive, the happier. Six to twenty-five months after stopping therapy, patients with colorectal cancer do not show any signs of the disease. tumor.
“This is a great progress for patients”D was happyr: Lewis Diaz, co-author of the study. Currently, standard treatment for metastatic colorectal cancer consists of chemotherapy and radiotherapy to reduce the size of the tumor, followed by surgery. Postoperative researches can be difficult for patients affected by work…
Source: Le Figaro
